AzPA Pharmacy Flash

• Dengue vaccine: What pharmacists need to know
  Although COVID-19 is not completely behind us, prepandemic life is starting to make a comeback. With stay-at-home orders being lifted and the Northern Hemisphere shifting to warmer weather, more people are venturing outside. So too are the mosquitoes, ticks, and fleas, anxiously awaiting the opportunity to feast on exposed skin and spread disease.
• CVS and Rite Aid limit emergency contraceptive purchases as demand surges after Roe ruling
  The shelf where emergency contraceptive pill Plan B typically sits at a CVS store on Washington Street in downtown Boston was empty less than a day after the Rhode Island-based pharmacy giant said it would be limiting purchases of the medication. Another CVS on Cambridge Street was down to three boxes.
• Lundbeck, Otsuka to seek new FDA approval for Rexulti after it reduced agitation in Alzheimer's patents
  Lundbeck of Denmark and Otsuka of Japan revealed that a phase 3 study of brexpiprazole in Alzheimer's patients showed that the drug for major depressive disorder reduced agitation (AAD) at a statistically significant rate when pitted against placebo.